Clinical trial · Interventional
Probiotics in Radiation-treated Gynecologic Cancer
NCT02351089CI-TRIAL-00043819ProRadterminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Slow recruitment
Summary
Brief summary (as posted)
The aim of the current Project is to study the efficacy of a probiotic Product in reducing the symptoms of gastrointestinal toxicity linked to the irradiation of gynecologic cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Toxicity | — | UNRESOLVED | — |
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Capsules placebo | Dietary Supplement | — | UNRESOLVED |
| Capsules probiotic powder and corn starch | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- capsules containing corn starch
- interventionNames
- Dietary Supplement: Capsules placebo
- type
- ACTIVE_COMPARATOR
- label
- Probiotic low dose
- description
- capsules containing probiotic powder and corn starch
- interventionNames
- Dietary Supplement: Capsules probiotic powder and corn starch
- type
- ACTIVE_COMPARATOR
- label
- Probiotic high dose
- description
- capsules containing probiotic powder and corn starch
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women diagnosed with cancer in the small pelvis and waiting to receive radiotherapy either as a primary or as a secondary treatment following surgery. Chemotherapy may or may not be part of the treatment regimen. * Age, older than 18 years old. * Agreement for participation in the study by signed written informed consent. Exclusion Criteria: * Previously treated with irradiation of the pelvic area. * Reluctance to refrain from using other probiotic products during the participation in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.